Skip to content

Modular measuring systems for the individual therapy and care of dementia patients

Modular measuring systems for the individual therapy and care of dementia patients - Pyramid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012765
Enrollment
560
Registered
2017-10-25
Start date
2017-11-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F01 F02 F03

Interventions

Group 1: Dementia sufferers and their social reference persons are questioned once using a questionnaire on the use of technical assistance systems

Sponsors

Charité – Universitätsmedizin Berlin, Klinik m.S. Rheumatologie und Klinische Immunologie CC12
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Early to middle stages of cognitive disorders, patients with rheumatic diseases, relatives, reference persons

Exclusion criteria

Exclusion criteria: Later disease stages of dementia or cognitive impairments, which lead to non-acceptance, Non-compliant, protected persons, Psychiatric disorder, which limits the understanding of the project plan (not consentable), Prisoner or a person who is placed in a clinic by an administrative or judicial order.

Design outcomes

Primary

MeasureTime frame
Which subjectively and objectively measurable indicators are necessary to support persons with cognitive impairments in the life day with a technical assistance system? The data are collected with a standardized questionnaire.

Secondary

MeasureTime frame
Which parameters are used by cognitively impaired persons and their social reference persons (eg relatives, caregivers and nurses), so that a technical measuring system provides support in everyday life with the aim of the long-term independent and self-determined life-cycle of dementia patients?

Countries

Germany

Contacts

Public ContactAxel Steinbach

Studiengruppe Insider, Charité – Universitätsmedizin Berlin, Klinik m.S. Rheumatologie und Klinische Immunologie CC12

axel.steinbach@charite.de+49 30 450 513 133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026